Microglial activation in neuroinflammation: implications for the etiology of neurodegeneration

Yoko S Kaneko1, Akira Nakashima, Keiji Mori

  • 1Department of Physiology, Fujita Health University School of Medicine, Toyoake, Japan.

Abstract

Insights

Activated microglia, key in neurodegeneration, survive longer when treated with lipopolysaccharide (LPS). This survival is linked to increased Bcl-xL, inhibiting cell death and autophagy, suggesting a role in disease progression.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Activated microglia release inflammatory cytokines, potentially driving neurodegenerative diseases.
  • The precise mechanisms governing microglial activation and survival are not fully understood.

Purpose of the Study:

  • To investigate the regulation of activated microglia concerning their cell death and survival pathways.
  • To elucidate the molecular mechanisms behind microglial longevity under specific stimuli.

Main Methods:

  • Utilized primary mouse microglia cultures.
  • Maintained microglia in culture with sublethal lipopolysaccharide (LPS) concentrations to promote activation and survival.
  • Assessed cell death (apoptosis, necrosis), protein levels (Bcl-2-associated X protein, Bcl-xL), and autophagy markers (microtubule-associated light chain 3-II).

Main Results:

  • Lipopolysaccharide (LPS) treatment induced morphological changes in microglia.
  • LPS exposure did not alter the proapoptotic Bcl-2-associated X protein but increased the antiapoptotic Bcl-xL protein level.
  • A decrease in microtubule-associated light chain 3-II, an autophagy marker, was observed 3 hours post-LPS exposure.

Conclusions:

  • Elevated Bcl-xL appears to concurrently inhibit apoptosis and autophagy in activated microglia.
  • Sustained microglial activation and survival, induced by optimal LPS doses, may significantly contribute to the advancement of neurodegenerative conditions.